CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Drugs (New Approvals & NDA)
Original article

FDA Expedited Investigational New Drug (IND) Pilot Program

RegulatoryNeutral
AI Analysis

Summary

The FDA announced the Expedited IND Pilot Program under HHS Operation TrialBlazer to evaluate new approaches for accelerating first-in-human clinical trials while maintaining safety and scientific standards.

Importance:2/10
Sentiment:
0.00
FDAINDRegulatoryFirst-in-humanOperation TrialBlazer

Read the original article

Published by FDA Drugs (New Approvals & NDA) on September 15, 2026 3:26 PM

Read Original